Location History:
- Naples, IT (2021 - 2023)
- Caserta, IT (2023)
Company Filing History:
Years Active: 2021-2024
Title: Innovations by Livio Luongo: Pioneering Treatments for Autism Spectrum Disorder
Introduction
Livio Luongo is an inventive mind hailing from Naples, Italy, recognized for his impactful contributions to medical science. With a total of four patents to his name, Luongo specializes in the use of cannabinoids for addressing neurodevelopmental disorders, particularly autism spectrum disorder (ASD).
Latest Patents
Luongo's most recent inventions focus on the therapeutic potential of cannabidiolic acid (CBDA) and cannabidivarin (CBDV). His patent titled "Use of cannabidiolic acid in the treatment of autism spectrum disorder and associated disorders" explores the efficacy of CBDA in treating ASD and various associated conditions, such as Fragile X syndrome, Rett syndrome, and Angelman syndrome. The invention details that CBDA is effective in enhancing cognitive functions in rodent models and suggests that the substance may be presented in a highly purified form, ensuring greater than 95% concentration in the total extract.
Another significant patent by Luongo is "Use of cannabidivarin in the treatment of autism spectrum disorder, associated disorders, and schizophrenia." This invention outlines the benefits of CBDV in treating not only ASD and its associated disorders but also schizophrenia. Similar to his work with CBDA, this invention indicates that CBDV can improve cognitive dysfunction in relevant rodent models and emphasizes the importance of highly pure extracts in medical applications.
Career Highlights
Currently, Livio Luongo works at GW Research Limited, a prominent company in cannabinoid research. His innovative approach to using cannabinoids in the treatment of neurological disorders showcases his commitment to advancing medical science and providing new solutions for patients.
Collaborations
Throughout his career, Luongo has collaborated with esteemed colleagues such as James Brodie and Marie Woolley-Roberts. These partnerships reflect a collective effort in exploring the therapeutic applications of cannabinoids, broadening the scope of research in this dynamic field.
Conclusion
Livio Luongo's contributions to the science of treating autism and related disorders mark him as a significant figure in the field of cannabinoid research. His groundbreaking patents not only open new avenues for treatment but also highlight the potential of innovative solutions in addressing complex medical challenges. Through his work at GW Research Limited, Luongo continues to be an integral part of the evolving landscape of medicinal innovations.